Table 2.
Mortality rate ratios for death from cancer, associated with prior cutaneous squamous cell carcinoma in persons diagnosed with cancer of the lung, colon, rectum, breast, prostate, or non-Hodgkin's lymphoma (NHL) in Denmark 1982-2003
| Unadjusted MRR (95% CI) |
Adjusteda MRR (95% CI) |
|
|---|---|---|
| Lung cancer | 1.27 (1.09-1.48) | 1.23 (1.05-1.43) |
| Colon cancer | 1.31 (1.06-1.61) | 1.13 (0.92-1.40) |
| Rectal cancer | 1.53 (1.19-1.98) | 1.29 (1.00-1.67) |
| Breast cancer | 1.37 (1.05-1.81) | 1.09 (0.82-1.43) |
| Prostate cancer | 1.11 (0.93-1.32) | 0.97 (0.81-1.15) |
| NHLb | 1.46 (1.09-1.96) | 1.09 (0.81-1.47) |
| Overall | 1.24 (1.14-1.35) | 1.13 (1.04-1.23) |
CI: confidence interval
aAll estimates are adjusted for age group, age group divided by exact age for each individual, gender, Charlson comorbidity index (low, medium, high), calendar period (1982-1986, 1987-1991, 1992-1996, 1997-2001, 2002-2003), a history of any autoimmune disease (yes/no), stage (localized, regional, distant, or unknown/missing), and the following index cancer treatments: no/symptomatic, chemotherapy, radiation therapy, hormone therapy, operation, and other/missing treatment
bIncludes the phenotypic variant chronic lymphocytic leukemia